These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 38188020)
1. Epigenomic reprogramming of therapy-resistant circulating tumor cells in colon cancer. Bao-Caamano A; Costa-Fraga N; Cayrefourcq L; Rodriguez-Casanova A; Muinelo-Romay L; López-López R; Alix-Panabières C; Díaz-Lagares A Front Cell Dev Biol; 2023; 11():1291179. PubMed ID: 38188020 [TBL] [Abstract][Full Text] [Related]
2. Epigenomic analysis reveals a unique DNA methylation program of metastasis-competent circulating tumor cells in colorectal cancer. Bao-Caamano A; Costa-Fraga N; Cayrefourcq L; Jácome MA; Rodriguez-Casanova A; Muinelo-Romay L; López-López R; Alix-Panabières C; Díaz-Lagares A Sci Rep; 2023 Sep; 13(1):15401. PubMed ID: 37717096 [TBL] [Abstract][Full Text] [Related]
3. Selective treatment pressure in colon cancer drives the molecular profile of resistant circulating tumor cell clones. Cayrefourcq L; Thomas F; Mazard T; Assenat E; Assou S; Alix-Panabières C Mol Cancer; 2021 Feb; 20(1):30. PubMed ID: 33557844 [TBL] [Abstract][Full Text] [Related]
4. High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors. Smit DJ; Cayrefourcq L; Haider MT; Hinz N; Pantel K; Alix-Panabières C; Jücker M Cells; 2020 Sep; 9(9):. PubMed ID: 32962206 [TBL] [Abstract][Full Text] [Related]
5. DNA methylome profiling of circulating tumor cells in lung cancer at single base-pair resolution. Zhao L; Wu X; Zheng J; Dong D Oncogene; 2021 Mar; 40(10):1884-1895. PubMed ID: 33564067 [TBL] [Abstract][Full Text] [Related]
6. Eslami-S Z; Cortés-Hernández LE; Glogovitis I; Antunes-Ferreira M; D'Ambrosi S; Kurma K; Garima F; Cayrefourcq L; Best MG; Koppers-Lalic D; Wurdinger T; Alix-Panabières C Front Cell Dev Biol; 2023; 11():1209846. PubMed ID: 37601099 [No Abstract] [Full Text] [Related]
7. mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients. Mostert B; Sieuwerts AM; Bolt-de Vries J; Kraan J; Lalmahomed Z; van Galen A; van der Spoel P; de Weerd V; Ramírez-Moreno R; Smid M; Verhoef C; IJzermans JN; Gratama JW; Sleijfer S; Foekens JA; Martens JW Mol Oncol; 2015 Apr; 9(4):920-32. PubMed ID: 25655581 [TBL] [Abstract][Full Text] [Related]
8. DNA methylome profiling identifies novel methylated genes in African American patients with colorectal neoplasia. Ashktorab H; Daremipouran M; Goel A; Varma S; Leavitt R; Sun X; Brim H Epigenetics; 2014 Apr; 9(4):503-12. PubMed ID: 24441198 [TBL] [Abstract][Full Text] [Related]
9. Impact of Colon-Specific DNA Methylation-Regulated Gene Modules on Colorectal Cancer Patient Survival. Yu H; Jiang W; Chen G; Yang F; Zhao X; Ji Z; Ni J; Fu Y; Chen F; Zhao B Med Sci Monit; 2019 May; 25():3549-3557. PubMed ID: 31083646 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of Gene Expression and DNA Methylation Markers in Circulating Tumor Cells and Paired Plasma Derived Exosomes in Metastatic Castration Resistant Prostate Cancer. Zavridou M; Strati A; Bournakis E; Smilkou S; Tserpeli V; Lianidou E Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33668490 [TBL] [Abstract][Full Text] [Related]
12. Establishment and characterization of a cell line from human circulating colon cancer cells. Cayrefourcq L; Mazard T; Joosse S; Solassol J; Ramos J; Assenat E; Schumacher U; Costes V; Maudelonde T; Pantel K; Alix-Panabières C Cancer Res; 2015 Mar; 75(5):892-901. PubMed ID: 25592149 [TBL] [Abstract][Full Text] [Related]
13. Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer. Davis AA; Zhang Q; Gerratana L; Shah AN; Zhan Y; Qiang W; Finkelman BS; Flaum L; Behdad A; Gradishar WJ; Platanias LC; Cristofanilli M Breast Cancer Res; 2019 Dec; 21(1):137. PubMed ID: 31801599 [TBL] [Abstract][Full Text] [Related]
14. Molecular Portrait of Metastasis-Competent Circulating Tumor Cells in Colon Cancer Reveals the Crucial Role of Genes Regulating Energy Metabolism and DNA Repair. Alix-Panabières C; Cayrefourcq L; Mazard T; Maudelonde T; Assenat E; Assou S Clin Chem; 2017 Mar; 63(3):700-713. PubMed ID: 28007957 [TBL] [Abstract][Full Text] [Related]
15. Gene signatures of circulating breast cancer cell models are a source of novel molecular determinants of metastasis and improve circulating tumor cell detection in patients. Fina E; Cleris L; Dugo M; Lecchi M; Ciniselli CM; Lecis D; Bianchi GV; Verderio P; Daidone MG; Cappelletti V J Exp Clin Cancer Res; 2022 Feb; 41(1):78. PubMed ID: 35216615 [TBL] [Abstract][Full Text] [Related]
16. Circulating tumor cell enumeration for improved screening and disease detection of patients with colorectal cancer. Tsai WS; Hung WS; Wang TM; Liu H; Yang CY; Wu SM; Hsu HL; Hsiao YC; Tsai HJ; Tseng CP Biomed J; 2021 Dec; 44(6 Suppl 2):S190-S200. PubMed ID: 35292267 [TBL] [Abstract][Full Text] [Related]
17. Diversity of Epithelial-Mesenchymal Phenotypes in Circulating Tumour Cells from Prostate Cancer Patient-Derived Xenograft Models. Hassan S; Blick T; Thompson EW; Williams ED Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34206049 [TBL] [Abstract][Full Text] [Related]
18. Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial. Larsson AM; Jansson S; Bendahl PO; Levin Tykjaer Jörgensen C; Loman N; Graffman C; Lundgren L; Aaltonen K; Rydén L Breast Cancer Res; 2018 Jun; 20(1):48. PubMed ID: 29884204 [TBL] [Abstract][Full Text] [Related]
19. Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in Pailler E; Faugeroux V; Oulhen M; Mezquita L; Laporte M; Honoré A; Lecluse Y; Queffelec P; NgoCamus M; Nicotra C; Remon J; Lacroix L; Planchard D; Friboulet L; Besse B; Farace F Clin Cancer Res; 2019 Nov; 25(22):6671-6682. PubMed ID: 31439588 [TBL] [Abstract][Full Text] [Related]
20. Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC counts. Lorente D; Olmos D; Mateo J; Dolling D; Bianchini D; Seed G; Flohr P; Crespo M; Figueiredo I; Miranda S; Scher HI; Terstappen LWMM; de Bono JS Ann Oncol; 2018 Jul; 29(7):1554-1560. PubMed ID: 29741566 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]